Share Price and Basic Stock Data
Last Updated: January 23, 2026, 6:35 pm
| PEG Ratio | -1.77 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ICDS Ltd operates within the Finance & Investments sector, with a current market capitalization of ₹57.3 Cr and its stock trading at ₹44.0. The company has demonstrated fluctuating revenue trends over the past few quarters. For instance, sales reported in September 2022 were ₹0.46 Cr, which rose to ₹0.60 Cr by March 2023. However, sales saw a dip to ₹0.50 Cr in June 2023 before recovering to ₹0.57 Cr in September 2023. The most significant growth occurred in March 2025, where sales surged to ₹2.35 Cr, representing a notable increase compared to previous quarters. Overall, the trailing twelve months (TTM) sales stood at ₹4.16 Cr, indicating a recovery trajectory following previous lows. This upward trend in sales, particularly in the latter half of FY 2025, suggests a positive shift in operational performance, aligning with recovery trends observed across the financial sector post-pandemic.
Profitability and Efficiency Metrics
ICDS Ltd’s profitability metrics reflect a mixed performance. The operating profit margin (OPM) reported for September 2022 was a healthy 52.17%, although it fluctuated significantly, dipping to 4.17% in December 2022. The latest OPM stood at 16.98%, indicating a need for improvement to align with industry standards. The company recorded a net profit of ₹1.13 Cr for the most recent reporting period, with a corresponding net profit margin of 35.95% for FY 2025, showcasing a strong recovery from prior losses. The return on equity (ROE) was reported at 6.05%, while the return on capital employed (ROCE) was 11.85%, both of which are lower than typical sector benchmarks. The interest coverage ratio (ICR) stood at a robust 43.24x, highlighting strong earnings relative to interest obligations. Despite some volatility in profitability, the company appears to be on a path toward enhanced efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of ICDS Ltd exhibits a strong liquidity position, evidenced by a current ratio of 4.96x and a quick ratio of the same value. This indicates that the company has ample short-term assets to cover its liabilities. Total borrowings stood at a mere ₹0.09 Cr, a stark contrast to total assets of ₹33.09 Cr, showcasing a low-debt profile that enhances financial stability. The company’s book value per share increased to ₹22.22 by March 2025, reflecting a solid foundation for shareholder equity. The price-to-book value (P/BV) ratio was reported at 1.93x, suggesting the stock is somewhat overvalued compared to its book value. However, the enterprise value of ₹54.26 Cr in relation to net operating revenue indicates a higher valuation, which may reflect investor confidence in future growth. Overall, the company’s balance sheet presents a conservative financial strategy, emphasizing liquidity over leverage.
Shareholding Pattern and Investor Confidence
ICDS Ltd’s shareholding structure reveals a significant promoter holding of 51.39%, which indicates strong control by the founding group. This stability is complemented by a slight presence of domestic institutional investors (DIIs) at 4.87%, while the public holds 43.73%. The number of shareholders has seen a minor decline, from 8,500 in March 2025 to 8,377 in September 2025, reflecting potential concerns regarding investor confidence. The consistent promoter ownership over the past quarters suggests a commitment to long-term strategic goals, which may bolster investor trust. However, the absence of foreign institutional investors (FIIs) could indicate limited international interest, potentially impacting future capital inflows. The overall shareholding pattern suggests a stable base but highlights the importance of increasing public and institutional participation to enhance market perception.
Outlook, Risks, and Final Insight
ICDS Ltd is positioned for potential growth, particularly as it has shown resilience in revenue recovery and profitability metrics. However, risks remain, including fluctuating operating profit margins and the need for sustained operational efficiency improvements. The company’s low debt levels provide a cushion against financial distress, yet the lack of FII participation could limit access to broader capital markets. Future growth hinges on the company’s ability to maintain revenue momentum while effectively managing expenses. Additionally, the ability to attract more institutional investors could enhance market confidence and share liquidity. In scenarios where the company successfully enhances its operational efficiency and stabilizes profit margins, it may attract increased investor interest, driving stock performance. Conversely, any setbacks in revenue growth or profitability could lead to a reassessment of its market position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| MKVentures Capital Ltd | 387 Cr. | 1,006 | 1,900/954 | 50.0 | 287 | 0.02 % | 16.6 % | 9.56 % | 10.0 |
| My Money Securities Ltd | 68.6 Cr. | 40.8 | 54.9/19.2 | 15.6 | 0.00 % | 44.0 % | 29.8 % | 10.0 | |
| Nam Securities Ltd | 46.9 Cr. | 87.0 | 135/68.6 | 195 | 21.6 | 0.00 % | 4.48 % | 3.22 % | 10.0 |
| ICDS Ltd | 56.3 Cr. | 43.2 | 68.5/36.9 | 49.8 | 23.0 | 0.00 % | 11.8 % | 6.05 % | 10.0 |
| HCKK Ventures Ltd | 11.9 Cr. | 32.0 | 165/26.5 | 74.2 | 12.1 | 0.00 % | 6.93 % | 5.14 % | 10.0 |
| Industry Average | 19,654.15 Cr | 1,373.80 | 45.11 | 3,630.28 | 0.43% | 11.38% | 25.55% | 6.85 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.46 | 0.48 | 0.60 | 0.50 | 0.57 | 0.50 | 0.71 | 0.52 | 0.53 | 0.51 | 2.35 | 0.77 | 0.53 |
| Expenses | 0.22 | 0.46 | 0.53 | 0.38 | 0.38 | 0.29 | 0.38 | 0.39 | 0.27 | 0.35 | 0.84 | 0.40 | 0.44 |
| Operating Profit | 0.24 | 0.02 | 0.07 | 0.12 | 0.19 | 0.21 | 0.33 | 0.13 | 0.26 | 0.16 | 1.51 | 0.37 | 0.09 |
| OPM % | 52.17% | 4.17% | 11.67% | 24.00% | 33.33% | 42.00% | 46.48% | 25.00% | 49.06% | 31.37% | 64.26% | 48.05% | 16.98% |
| Other Income | 1.48 | -0.09 | -0.65 | 0.99 | 0.81 | -0.05 | 0.20 | 0.71 | 0.70 | 0.39 | -0.48 | 1.27 | -0.17 |
| Interest | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Depreciation | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 1.62 | -0.17 | -0.69 | 1.00 | 0.89 | 0.05 | 0.42 | 0.73 | 0.85 | 0.44 | 0.92 | 1.53 | -0.18 |
| Tax % | 1.23% | 11.76% | 15.94% | 6.00% | 4.49% | 220.00% | 26.19% | 5.48% | 23.53% | 277.27% | 8.70% | 9.80% | 72.22% |
| Net Profit | 1.61 | -0.19 | -0.80 | 0.94 | 0.85 | -0.06 | 0.31 | 0.69 | 0.65 | -0.77 | 0.84 | 1.38 | -0.32 |
| EPS in Rs | 1.24 | -0.15 | -0.61 | 0.72 | 0.65 | -0.05 | 0.24 | 0.53 | 0.50 | -0.59 | 0.64 | 1.06 | -0.25 |
Last Updated: January 6, 2026, 10:37 pm
Below is a detailed analysis of the quarterly data for ICDS Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.77 Cr. (Jun 2025) to 0.53 Cr., marking a decrease of 0.24 Cr..
- For Expenses, as of Sep 2025, the value is 0.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Jun 2025) to 0.44 Cr., marking an increase of 0.04 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Jun 2025) to 0.09 Cr., marking a decrease of 0.28 Cr..
- For OPM %, as of Sep 2025, the value is 16.98%. The value appears to be declining and may need further review. It has decreased from 48.05% (Jun 2025) to 16.98%, marking a decrease of 31.07%.
- For Other Income, as of Sep 2025, the value is -0.17 Cr.. The value appears to be declining and may need further review. It has decreased from 1.27 Cr. (Jun 2025) to -0.17 Cr., marking a decrease of 1.44 Cr..
- For Interest, as of Sep 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 1.53 Cr. (Jun 2025) to -0.18 Cr., marking a decrease of 1.71 Cr..
- For Tax %, as of Sep 2025, the value is 72.22%. The value appears to be increasing, which may not be favorable. It has increased from 9.80% (Jun 2025) to 72.22%, marking an increase of 62.42%.
- For Net Profit, as of Sep 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 1.38 Cr. (Jun 2025) to -0.32 Cr., marking a decrease of 1.70 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.25. The value appears to be declining and may need further review. It has decreased from 1.06 (Jun 2025) to -0.25, marking a decrease of 1.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:32 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.06 | 5.60 | 4.83 | 2.80 | 6.45 | 3.28 | 3.11 | 3.09 | 1.42 | 1.92 | 2.28 | 3.90 | 4.16 |
| Expenses | 4.41 | 4.53 | 4.14 | 2.09 | 1.91 | 5.28 | 3.76 | 1.71 | 1.67 | 1.79 | 1.44 | 1.48 | 2.03 |
| Operating Profit | 0.65 | 1.07 | 0.69 | 0.71 | 4.54 | -2.00 | -0.65 | 1.38 | -0.25 | 0.13 | 0.84 | 2.42 | 2.13 |
| OPM % | 12.85% | 19.11% | 14.29% | 25.36% | 70.39% | -60.98% | -20.90% | 44.66% | -17.61% | 6.77% | 36.84% | 62.05% | 51.20% |
| Other Income | 1.84 | 0.44 | 0.20 | 6.72 | 0.06 | 0.46 | 0.37 | 0.06 | 6.59 | 0.83 | 1.96 | 0.96 | 1.01 |
| Interest | 0.50 | 0.33 | 0.14 | 0.14 | 0.07 | 0.06 | 0.08 | 0.08 | 0.07 | 0.06 | 0.08 | 0.08 | 0.07 |
| Depreciation | 0.08 | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 | 0.35 | 0.34 | 0.33 | 0.36 | 0.36 | 0.37 | 0.36 |
| Profit before tax | 1.91 | 1.03 | 0.61 | 7.15 | 4.39 | -1.74 | -0.71 | 1.02 | 5.94 | 0.54 | 2.36 | 2.93 | 2.71 |
| Tax % | 3.66% | 10.68% | 16.39% | 4.48% | 29.61% | 6.90% | 15.49% | 627.45% | 1.68% | 29.63% | 13.56% | 52.22% | |
| Net Profit | 1.75 | 0.90 | 0.51 | 6.84 | 3.10 | -1.87 | -0.81 | -5.38 | 5.84 | 0.38 | 2.04 | 1.40 | 1.13 |
| EPS in Rs | 1.34 | 0.69 | 0.39 | 5.25 | 2.38 | -1.44 | -0.62 | -4.13 | 4.48 | 0.29 | 1.57 | 1.07 | 0.86 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -48.57% | -43.33% | 1241.18% | -54.68% | -160.32% | 56.68% | -564.20% | 208.55% | -93.49% | 436.84% | -31.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 5.24% | 1284.51% | -1295.85% | -105.64% | 217.01% | -620.88% | 772.75% | -302.04% | 530.34% | -468.21% |
ICDS Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 5% |
| 3 Years: | 40% |
| TTM: | 81% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 27% |
| 3 Years: | 64% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| 1 Year: | 16% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | 5% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: December 4, 2025, 3:04 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 |
| Reserves | 2.59 | 3.48 | 3.99 | 11.56 | 14.62 | 12.66 | 11.81 | 6.34 | 12.19 | 12.49 | 14.51 | 15.92 | 16.98 |
| Borrowings | 4.78 | 1.31 | 1.31 | 0.12 | 0.54 | 0.72 | 0.20 | 0.14 | 0.48 | 0.30 | 0.13 | 0.26 | 0.09 |
| Other Liabilities | 21.59 | 21.21 | 20.59 | 20.26 | 4.30 | 1.07 | 0.96 | 0.98 | 0.91 | 1.01 | 1.00 | 2.98 | 2.99 |
| Total Liabilities | 41.99 | 39.03 | 38.92 | 44.97 | 32.49 | 27.48 | 26.00 | 20.49 | 26.61 | 26.83 | 28.67 | 32.19 | 33.09 |
| Fixed Assets | 0.26 | 0.24 | 0.20 | 7.61 | 7.49 | 7.38 | 11.11 | 10.77 | 10.74 | 10.38 | 9.99 | 9.73 | 9.58 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 11.24 | 8.76 | 8.63 | 8.29 | 7.18 | 4.01 | 2.50 | 4.54 | 4.15 | 4.34 | 5.82 | 5.81 | 6.00 |
| Other Assets | 30.49 | 30.03 | 30.09 | 29.07 | 17.82 | 16.09 | 12.39 | 5.18 | 11.72 | 12.11 | 12.86 | 16.65 | 17.51 |
| Total Assets | 41.99 | 39.03 | 38.92 | 44.97 | 32.49 | 27.48 | 26.00 | 20.49 | 26.61 | 26.83 | 28.67 | 32.19 | 33.09 |
Below is a detailed analysis of the balance sheet data for ICDS Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.03 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.03 Cr..
- For Reserves, as of Sep 2025, the value is 16.98 Cr.. The value appears strong and on an upward trend. It has increased from 15.92 Cr. (Mar 2025) to 16.98 Cr., marking an increase of 1.06 Cr..
- For Borrowings, as of Sep 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.26 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.17 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.98 Cr. (Mar 2025) to 2.99 Cr., marking an increase of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 33.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.19 Cr. (Mar 2025) to 33.09 Cr., marking an increase of 0.90 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9.58 Cr.. The value appears to be declining and may need further review. It has decreased from 9.73 Cr. (Mar 2025) to 9.58 Cr., marking a decrease of 0.15 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.81 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 0.19 Cr..
- For Other Assets, as of Sep 2025, the value is 17.51 Cr.. The value appears strong and on an upward trend. It has increased from 16.65 Cr. (Mar 2025) to 17.51 Cr., marking an increase of 0.86 Cr..
- For Total Assets, as of Sep 2025, the value is 33.09 Cr.. The value appears strong and on an upward trend. It has increased from 32.19 Cr. (Mar 2025) to 33.09 Cr., marking an increase of 0.90 Cr..
Notably, the Reserves (16.98 Cr.) exceed the Borrowings (0.09 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.13 | -0.24 | -0.62 | 0.59 | 4.00 | -2.72 | -0.85 | 1.24 | -0.73 | -0.17 | 0.71 | 2.16 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18.03 | 24.12 | 24.18 | 13.04 | 7.36 | 8.90 | 12.91 | 12.99 | 17.99 | 15.21 | 28.82 | 8.42 |
| Inventory Days | 2,269.53 | 2,265.81 | 2,488.49 | 12,045.00 | ||||||||
| Days Payable | 7.10 | 36.50 | 4.87 | 50.93 | ||||||||
| Cash Conversion Cycle | 2,280.47 | 2,253.42 | 2,507.80 | 12,007.11 | 7.36 | 8.90 | 12.91 | 12.99 | 17.99 | 15.21 | 28.82 | 8.42 |
| Working Capital Days | 571.30 | 736.52 | 767.78 | 1,449.57 | -181.65 | -42.29 | -62.20 | -3.54 | 1,657.92 | -26.61 | 966.93 | 355.64 |
| ROCE % | 12.36% | 7.12% | 4.09% | 33.88% | 16.86% | -6.15% | -3.69% | 4.94% | -2.26% | 2.33% | 9.12% | 11.85% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.08 | 1.56 | 0.29 | 4.48 | -4.13 |
| Diluted EPS (Rs.) | 1.08 | 1.56 | 0.29 | 4.48 | -4.13 |
| Cash EPS (Rs.) | 1.36 | 1.84 | 0.57 | 4.73 | -3.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.22 | 21.14 | 19.59 | 19.36 | 14.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.22 | 21.14 | 19.59 | 19.36 | 14.86 |
| Revenue From Operations / Share (Rs.) | 3.00 | 1.75 | 1.48 | 0.89 | 0.80 |
| PBDIT / Share (Rs.) | 2.59 | 2.15 | 0.73 | -0.13 | 1.10 |
| PBIT / Share (Rs.) | 2.31 | 1.87 | 0.45 | -0.39 | 0.84 |
| PBT / Share (Rs.) | 2.25 | 1.81 | 0.40 | 4.56 | 0.78 |
| Net Profit / Share (Rs.) | 1.08 | 1.56 | 0.29 | 4.48 | -4.13 |
| NP After MI And SOA / Share (Rs.) | 1.08 | 1.56 | 0.29 | 4.48 | -4.13 |
| PBDIT Margin (%) | 86.56 | 122.88 | 50.00 | -15.42 | 137.40 |
| PBIT Margin (%) | 77.12 | 106.93 | 31.08 | -43.85 | 104.89 |
| PBT Margin (%) | 75.12 | 103.61 | 27.76 | 508.35 | 97.25 |
| Net Profit Margin (%) | 35.95 | 89.34 | 19.78 | 499.70 | -514.33 |
| NP After MI And SOA Margin (%) | 35.95 | 89.34 | 19.78 | 499.70 | -514.33 |
| Return on Networth / Equity (%) | 4.84 | 7.39 | 1.49 | 23.14 | -27.79 |
| Return on Capital Employeed (%) | 10.19 | 8.68 | 2.27 | -1.98 | 5.46 |
| Return On Assets (%) | 4.35 | 7.10 | 1.41 | 21.93 | -26.27 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.12 | 0.08 | 0.07 | 0.04 | 0.04 |
| Current Ratio (X) | 4.96 | 24.79 | 15.72 | 14.56 | 15.80 |
| Quick Ratio (X) | 4.96 | 24.79 | 15.72 | 14.56 | 15.80 |
| Interest Coverage Ratio (X) | 43.24 | 36.98 | 15.07 | -2.46 | 18.00 |
| Interest Coverage Ratio (Post Tax) (X) | 18.96 | 27.89 | 6.96 | -8.39 | -66.37 |
| Enterprise Value (Cr.) | 54.26 | 45.36 | 17.71 | 50.49 | 53.03 |
| EV / Net Operating Revenue (X) | 13.91 | 19.91 | 9.21 | 43.23 | 50.67 |
| EV / EBITDA (X) | 16.07 | 16.20 | 18.42 | -280.32 | 36.88 |
| MarketCap / Net Operating Revenue (X) | 14.33 | 21.42 | 11.76 | 44.62 | 52.97 |
| Price / BV (X) | 1.93 | 1.77 | 0.88 | 2.07 | 2.86 |
| Price / Net Operating Revenue (X) | 14.33 | 21.42 | 11.76 | 44.64 | 52.99 |
| EarningsYield | 0.02 | 0.04 | 0.01 | 0.11 | -0.09 |
After reviewing the key financial ratios for ICDS Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 5. It has decreased from 1.56 (Mar 24) to 1.08, marking a decrease of 0.48.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 5. It has decreased from 1.56 (Mar 24) to 1.08, marking a decrease of 0.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.36. This value is below the healthy minimum of 3. It has decreased from 1.84 (Mar 24) to 1.36, marking a decrease of 0.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.22. It has increased from 21.14 (Mar 24) to 22.22, marking an increase of 1.08.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.22. It has increased from 21.14 (Mar 24) to 22.22, marking an increase of 1.08.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3.00. It has increased from 1.75 (Mar 24) to 3.00, marking an increase of 1.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.59. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 2.59, marking an increase of 0.44.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 2.31, marking an increase of 0.44.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.25. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 2.25, marking an increase of 0.44.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has decreased from 1.56 (Mar 24) to 1.08, marking a decrease of 0.48.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has decreased from 1.56 (Mar 24) to 1.08, marking a decrease of 0.48.
- For PBDIT Margin (%), as of Mar 25, the value is 86.56. This value is within the healthy range. It has decreased from 122.88 (Mar 24) to 86.56, marking a decrease of 36.32.
- For PBIT Margin (%), as of Mar 25, the value is 77.12. This value exceeds the healthy maximum of 20. It has decreased from 106.93 (Mar 24) to 77.12, marking a decrease of 29.81.
- For PBT Margin (%), as of Mar 25, the value is 75.12. This value is within the healthy range. It has decreased from 103.61 (Mar 24) to 75.12, marking a decrease of 28.49.
- For Net Profit Margin (%), as of Mar 25, the value is 35.95. This value exceeds the healthy maximum of 10. It has decreased from 89.34 (Mar 24) to 35.95, marking a decrease of 53.39.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 35.95. This value exceeds the healthy maximum of 20. It has decreased from 89.34 (Mar 24) to 35.95, marking a decrease of 53.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.84. This value is below the healthy minimum of 15. It has decreased from 7.39 (Mar 24) to 4.84, marking a decrease of 2.55.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.19. This value is within the healthy range. It has increased from 8.68 (Mar 24) to 10.19, marking an increase of 1.51.
- For Return On Assets (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 5. It has decreased from 7.10 (Mar 24) to 4.35, marking a decrease of 2.75.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.12. It has increased from 0.08 (Mar 24) to 0.12, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 4.96. This value exceeds the healthy maximum of 3. It has decreased from 24.79 (Mar 24) to 4.96, marking a decrease of 19.83.
- For Quick Ratio (X), as of Mar 25, the value is 4.96. This value exceeds the healthy maximum of 2. It has decreased from 24.79 (Mar 24) to 4.96, marking a decrease of 19.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 43.24. This value is within the healthy range. It has increased from 36.98 (Mar 24) to 43.24, marking an increase of 6.26.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 18.96. This value is within the healthy range. It has decreased from 27.89 (Mar 24) to 18.96, marking a decrease of 8.93.
- For Enterprise Value (Cr.), as of Mar 25, the value is 54.26. It has increased from 45.36 (Mar 24) to 54.26, marking an increase of 8.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.91. This value exceeds the healthy maximum of 3. It has decreased from 19.91 (Mar 24) to 13.91, marking a decrease of 6.00.
- For EV / EBITDA (X), as of Mar 25, the value is 16.07. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 16.07, marking a decrease of 0.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 14.33. This value exceeds the healthy maximum of 3. It has decreased from 21.42 (Mar 24) to 14.33, marking a decrease of 7.09.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.77 (Mar 24) to 1.93, marking an increase of 0.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 14.33. This value exceeds the healthy maximum of 3. It has decreased from 21.42 (Mar 24) to 14.33, marking a decrease of 7.09.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ICDS Ltd:
- Net Profit Margin: 35.95%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.19% (Industry Average ROCE: 11.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.84% (Industry Average ROE: 25.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 18.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.8 (Industry average Stock P/E: 45.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 35.95%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | Syndicate House, Upendra Nagar, Manipal Karnataka 576104 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sujir Prabhakar | Chairman & Managing Director |
| Mr. T Sachin Pai | Non Executive Director |
| Mr. K Umesh Kini | Non Executive Director |
| Mrs. Roopashree | Non Exe. Women Independent Director |
| Mr. K Bhujangesha Kamath | Non Exe. & Ind. Director |
| Mr. Jayaram V Prabhu | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of ICDS Ltd?
ICDS Ltd's intrinsic value (as of 25 January 2026) is ₹40.65 which is 5.90% lower the current market price of ₹43.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹56.3 Cr. market cap, FY2025-2026 high/low of ₹68.5/36.9, reserves of ₹16.98 Cr, and liabilities of ₹33.09 Cr.
What is the Market Cap of ICDS Ltd?
The Market Cap of ICDS Ltd is 56.3 Cr..
What is the current Stock Price of ICDS Ltd as on 25 January 2026?
The current stock price of ICDS Ltd as on 25 January 2026 is ₹43.2.
What is the High / Low of ICDS Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ICDS Ltd stocks is ₹68.5/36.9.
What is the Stock P/E of ICDS Ltd?
The Stock P/E of ICDS Ltd is 49.8.
What is the Book Value of ICDS Ltd?
The Book Value of ICDS Ltd is 23.0.
What is the Dividend Yield of ICDS Ltd?
The Dividend Yield of ICDS Ltd is 0.00 %.
What is the ROCE of ICDS Ltd?
The ROCE of ICDS Ltd is 11.8 %.
What is the ROE of ICDS Ltd?
The ROE of ICDS Ltd is 6.05 %.
What is the Face Value of ICDS Ltd?
The Face Value of ICDS Ltd is 10.0.